Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...
The World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) have officially classified the Hepatitis D virus (HDV) as carcinogenic to humans. This places HDV ...
Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target hepatitis B virus surface antigen (HBsAg). Their efficacy and safety in the treatment of chronic hepatitis D ...
Two emerging pathogens with animal origins - influenza D virus and canine coronavirus - have so far been quietly flying under the radar, but researchers warn conditions are ripe for the viruses to ...
Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.